ChildLife® Pure DHA provides concentrated DHA in a tasty, easy to use, naturally flavored soft gel that can be chewed or swallowed. Our DHA is sourced from the purest cod liver oil available. The contents of each capsule are tested for any contaminants including PCBs, dioxins, metals, mercury or other toxins, and exceeds the highest international standards for purity.
Our gelatin is derived from fish, while most other brands use pork or beef gelatin.
DHA plays a vital role in how well a child’s brain can grow and function. Up to 60% of the human brain is built from, runs on, and is constructed from essential fats and oils. DHA continues to be the most prevalent and vital nutrient within these oils for supporting healthy brain function and development.*
ChildLife® uses only the highest quality ingredients.
This formula is gluten free, casein free and alcohol free. It contains no milk, eggs, wheat, yeast or corn. No artificial colorings, flavorings or sweeteners.
For infants 6 mo.–1 yr: 1-2 capsules daily (open soft gel)
For children 2-4 yrs: 4-6 capsules daily
For children 5-12 yrs: 6-8 capsules daily
• Store in a cool, dry place, away from sunlight.
Purified Arctic Cod Liver Oil, Purified Water, Gelatin, Glycerin, Natural Berry Flavor.
*These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure or prevent any disease.
Helland, I.B., Smith, L., Saarem, K.., Saugstad O.D., Drevon, C.A., “Maternal supplementation with very-long-chain n-3 fatty acids during pregnancy and lactation augments children’s IQ at 4 years of age.” Pediatrics. 2003 111(1) 39-44.
Bourre, J.M., “Omega-3 fatty acids in psychiatry.” Medical Science (Paris). 2005 Feb;21(2): 216-21.
Vancassel S., Durand G., Barthelemy C., Lejeune B., MArtineau J., Guilloteau D., Andres C., Chalon S. “Plasma fatty acid levels in autistic children.” Prostaglandins Leukot Essent Fatty Acids. 2001. Jul;65(1):1-7.
Farooqu A.A., Horrocks L.A., “Plasmalogens, phospholipase A2, and docosahexaenoic acid turnover in brain tissue.” J Mol Neurosci. 2001 Apr-Jun; 16(2-3): 263-72.
Crawford MA. Golfetto I et. al. “The potential role for arachidonic and docosahexaenoic acid in protection against some central nervous system injuries in preterm infants.” Lipids. 2003. Apr; 38(4): 303-15.
Bell JG., MacKinlay EE., Dick JR., MacDonald DJ., Boyle RM., Glen AC. “Essential fatty acids and phospholipase A2 in autistic spectrum disorders.” Prostaglandins Leukot Essent Fatty Acids. 2004. Oct;71(4):201-4.
Ruxton C. “Health benefits of omega-3 fatty acids.” Nurs Stand. 2004. Aug 11-17; 18(48): 38-42.
Morale S.E., Hoffman D.R., Castaneda Y.S., Wheaton D.H.,Burns R.A., Birch E.E., “Duration of long-chain polyunsaturated fatty acids availability in the diet and visual acuity.” Early Hum Dev. 2005. Feb; 81(2): 197-203.
Su KP. “Mind-body interface: the role of n-3 fatty acids in psychoneuroimmunology, somatic presentation, and medical illness comorbidity of depression.” Asia Pac J Clin Nutr. 2008;17 Suppl 1:151-7.